The United Kingdom leads the global export of alkaloids not in dosage forms with significant dominance, although experiencing a slight decline in 2023. The following countries like the United States, Italy, and the Netherlands show varied growth trends, with Italy witnessing substantial growth. Eastern European countries like Romania and Austria exhibit strong growth, with exceptional increases in Austria. Countries such as Norway, despite its small market share, show impressive growth rates in 2023. Meanwhile, South Africa and Germany's exports decreased, and countries like Denmark and Guyana experienced significant contractions over the last year.
Future trends to watch for include:
- The potential for further market stabilization or fluctuations in the United Kingdom.
- Continued growth in Italy and Romania may influence overall European export dynamics.
- Emerging growth opportunities in Eastern Europe with a focus on Austria.
- Monitoring Norway's rapid growth for potential entry strategies or competition.
Top countries in Export of Alkaloids Not in Dosage Forms by Country
| # | 10 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United Kingdom | 312,280,000 | 2023 | +5.26% | -0.96% | View data |
| 2 | 2 United States | 14,955,000 | 2023 | +1.8% | +0.48% | View data |
| 3 | 3 Italy | 9,776,400 | 2023 | +3.98% | +5.03% | View data |
| 4 | 4 Netherlands | 8,009,200 | 2023 | +6.57% | +1.25% | View data |
| 5 | 5 Romania | 7,824,500 | 2023 | +6.24% | +6.33% | View data |
| 6 | 6 Belgium | 6,448,700 | 2023 | +4.6% | +6.77% | View data |
| 7 | 7 China | 3,554,600 | 2023 | +0.92% | +4.18% | View data |
| 8 | 8 France | 2,681,900 | 2023 | -0.49% | +8.4% | View data |
| 9 | 9 Colombia | 956,620 | 2023 | +5.67% | +6.56% | View data |
| 10 | 10 South Africa | 922,420 | 2023 | -6.53% | -5.68% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...